[CA 19-9 in the differential diagnosis of pancreatic lesions].

Der Internist
S StintzingF Boxberger

Abstract

CA 19-9 is still used in the differential diagnosis of pancreatic lesions. As it has been shown to be elevated in many other non-pancreatic diseases--sometimes even extraordinarily--this marker should not be used to set the diagnosis of a pancreas carcinoma anymore. Especially if there is a concomitant cholestasis there is no diagnostic value to perform the measurement of CA 19-9. As the histological confirmation is the only way to get the exact diagnosis endoscopic ultrasound guided fine-needle aspiration biopsy should be considered in lesions of the pancreatic head.

References

Nov 1, 1979·Somatic Cell Genetics·H KoprowskiP Fuhrer
Apr 3, 1981·Science·H KoprowskiH F Sears
Oct 4, 2000·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·D V MannG Glazer
Apr 23, 2005·Digestive Diseases and Sciences·Javier L ParraJamie S Barkin
Jun 4, 2005·Gastrointestinal Endoscopy·Keith E VolmarH Bill Xie
Jul 4, 2007·Zeitschrift für Gastroenterologie·G AdlerI Kopp

❮ Previous
Next ❯

Citations

Aug 5, 2008·Der Internist·M P Lutz, S Pourebrahim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.